Cardiomyopathy Etiology Affects Catheter Ablation Outcomes in Atrial Fibrillation Patients
Patients with idiopathic dilated cardiomyopathy vs those with known heart disease had better outcomes in catheter ablation for atrial fibrillation.
Patients with idiopathic dilated cardiomyopathy vs those with known heart disease had better outcomes in catheter ablation for atrial fibrillation.
For patients with nonvalvular atrial fibrillation, left atrial appendage closure may be the most cost-effective stroke prevention measure vs warfarin and NOACS.
Five cases of probable interaction, including severe renal impairment, between the anticoagulant acenocoumarol and levofloxacin were described in patients with atrial fibrillation.
Left atrial functional improvement independently predicated atrial fibrillation-free survival after cardiac resynchronization therapy.
Central sleep apnea and Cheyne Stokes respiration predict incident atrial fibrillation in older men.
Occlusion of the left atrial appendage provides protection against thromboembolic stroke in patients with nonvalvular atrial fibrillation.
Choosing the right anticoagulant agent can be a challenge for many reasons, including cost, familiarity, drug interactions, and reversibility.
Risk and prevalence of stroke in patients with undiagnosed asymptomatic atrial fibrillation remains problematic for patients and clinicians.
Recent trials have shown that cryoballoon catheter ablation has demonstrated success in treating atrial fibrillation among 74% of patients, presenting an alternative to traditional radiofrequency ablation.
A cardiorespiratory fitness routine can increase the benefits of weight loss.